In this video, Nitin Jain, MD, University of Texas MD Anderson Cancer Center, Houston, TX, discusses the use of autologous CAR-T cell products in the treatment of chronic lymphocytic leukemia (CLL), and challenges in this space. Dr Jain also highlights the promise of allogeneic CARs, and ongoing trials evaluating these agents. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
